References
<A NAME="RS03503ST-1A">1a</A>
Hiyama T.
Organofluorine
Compounds: Chemistry and Applications
Springer;
Berlin,
New York:
2000.
<A NAME="RS03503ST-1B">1b</A>
Banks RE.
Smart BE.
Tatlow JC.
Organofluorine
Chemistry: Principle and Commercial Applications
Plenum
Press;
New York:
1994.
<A NAME="RS03503ST-1C">1c</A>
Liebman JF.
Greenberg A.
Dolbier WR.
Fluorine-Containing
Molecules, Structure, Reactivity, Synthesis and Applications
VCH
Publishers;
Weinheim:
1988.
<A NAME="RS03503ST-2A">2a</A>
Filler R.
Kobayashi Y.
Yagupolskii LM.
Organofluorine
Compounds in Medicinal Chemistry and Biomedical Applications
Elsevier;
Amsterdam:
1993.
<A NAME="RS03503ST-2B">2b</A>
Ojima I.
McCarthy JR.
Welch JT.
Biomedical Frontiers
of Fluorine Chemistry
ACS Symposium Series;
Washington
D. C.:
1996.
<A NAME="RS03503ST-2C">2c</A>
Kukhar VP.
Soloshonok VA.
Fluorine-Containing Amino Acids, Synthesis
and Properties
Wiley;
New York:
1995.
<A NAME="RS03503ST-3A">3a</A>
Lin P.
Jiang J.
Tetrahedron
2000,
56:
3635
<A NAME="RS03503ST-3B">3b</A>
Prakash GKS.
Yudin KA.
Chem.
Rev.
1997,
97:
757
<A NAME="RS03503ST-3C">3c</A>
Prakash GKS.
Mandal M.
J.
Fluorine Chem.
2001,
112:
123 ;
and references cited therein
<A NAME="RS03503ST-4A">4a</A>
Nelson DW.
Owens J.
Hiraldo D.
J. Org. Chem.
2001,
66:
2572
<A NAME="RS03503ST-4B">4b</A>
Prakash GKS.
Mandal M.
Olah GA.
Angew. Chem. Int. Ed.
2001,
40:
589
<A NAME="RS03503ST-4C">4c</A>
Bravo P.
Crucianelli M.
Vergani B.
Zanda M.
Tetrahedron Lett.
1998,
39:
7771
<A NAME="RS03503ST-4D">4d</A>
Xu Y.
Dolbier WR.
Tetrahedron Lett.
1998,
39:
9151
<A NAME="RS03503ST-5A">5a</A>
Dale JA.
Dull DL.
Mosher HS.
J. Org. Chem.
1969,
34:
2543
<A NAME="RS03503ST-5B">5b</A>
Goldberg Y.
Alper H.
J. Org. Chem.
1992,
57:
3731
<A NAME="RS03503ST-6A">6a</A>
Streinz L.
Svatos A.
Vrkoc J.
Meinwald J.
J.
Chem. Soc., Perkin Trans. 1
1994,
3509
<A NAME="RS03503ST-6B">6b</A>
Takahashi T.
Fukushima A.
Tanaka Y.
Segawa M.
Hori H.
Takeuchi Y.
Burchardt A.
Haufe G.
Chirality
2000,
12:
458 ; and references cited therein
<A NAME="RS03503ST-7A">7a</A>
Dyachenko VI.
Kolomiets AF.
Fokin AV.
J.
Org. Chem. USSR (Engl. Transl.)
1992,
28:
1345
<A NAME="RS03503ST-7B">7b</A>
Dyachenko VI.
Kolomiets AF.
Fokin AV.
Izv. Akad. Nauk, Ser. Khim.
1995,
3:
528
<A NAME="RS03503ST-7C">7c</A>
Golubev AS.
Kolomiets AF.
Fokin AV.
Bull. Acad. Sci. USSR Div. Chem.
Sci.(Engl.Transl.)
1989,
38:
2180
<A NAME="RS03503ST-8A">8a</A>
Zhuang W.
Jorgensen KA.
Chem.
Commun.
2002,
1336
<A NAME="RS03503ST-8B">8b</A>
Zhuang W.
Gathergood N.
Hazell RG.
Jørgensen KA.
J. Org.
Chem.
2001,
66:
1009
<A NAME="RS03503ST-9">9</A>
Gong Y.
Kato K.
J. Fluorine Chem.
2002,
1-5:
5735
<A NAME="RS03503ST-10A">10a</A>
Hazeldine RN.
Kidd JM.
J. Chem. Soc.
1954,
4228
<A NAME="RS03503ST-10B">10b</A>
Olah GA.
Prakash GKS.
Sommer J.
Superacids
Wiley
Interscience;
New York:
1985.
<A NAME="RS03503ST-10C">10c</A>
Yato M.
Ohwada T.
Shudo K.
J.
Am. Chem. Soc.
1991,
113:
691
<A NAME="RS03503ST-10D">10d</A>
Sato Y.
Ohwada T.
Saito S.
Shudo K.
J. Am. Chem. Soc.
1995,
117:
3037
<A NAME="RS03503ST-11">11</A>
Boumizane K.
Herzog-Cance MH.
Jones DJ.
Pascal JL.
Potier J.
Roziere J.
Polyhedron
1991,
10:
2757
<A NAME="RS03503ST-12">12</A>
Olah GA.
Angew.
Chem., Int. Ed. Engl.
1993,
32:
767
<A NAME="RS03503ST-13">13</A>
Yamazaki T.
Saito S.
Ohwada T.
Shudo K.
Tetrahedron Lett.
1995,
36:
5749
<A NAME="RS03503ST-14">14</A>
New compounds were characterized by
NMR (1H, 19F, 13C) spectroscopy
using Bruker AM-360 spectrometer. The spectra were recorded in CDCl3 using
TMS and CCl3F as internal standards.
2,5-Di(α-carboethoxy-α-hydroxytrifluoroethyl)-pyrrole:
1H
NMR (360 MHz, CDCl3): δ 1.39 (t, J = 7.3 Hz, 6 H), 4.34-4.53
(m, 6 H), 6.44 (s, 1 H), 6.45 (s, 1 H), 9.18 (br s). 19F
NMR (338 MHz, CDCl3): δ -78.92 (s). 13C
NMR (90 MHz, CDCl3): δ 167.7, 122.4 (q, J = 285.5 Hz), 123.0, 122.9,
75.0 (q, J = 32.3 Hz), 64.8,
13.8.
3,3,3-Trifluoro-2-hydroxy-2-(4-methylphenyl)-propion-ic
acid ethyl ester:
1H NMR (250
MHz, CDCl3): δ 1.37 (t, J = 7.2
Hz, 3 H), 2.36 (s, 3 H), 4.30 (s, -OH), 4.31-4.52 (m, 2
H), 7.21 (d, J = 8.5 Hz, 2 H),
7.67 (d, 2 H). 19F NMR (470 MHz, CDCl3): δ
-76.98. 13C NMR (125 MHz,
CDCl3): δ 169.1, 139.6, 130.0, 129.1, 126.7,
123.1 (q, J = 285.5 Hz), 77.7
(q, J = 30.2 Hz), 64.3, 21.1,
13.9.
3,3,3-Trifluoro-2-hydroxy-2-(4-methoxyphenyl)-prop-ionic
acid ethyl ester:
1H NMR (360
MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.3
Hz), 3.82 (s, 3 H), 4.29 (s, -OH), 4.33-4.52 (m, 2 H),
6.93 (d, 1 H,
J = 9.0
Hz), 7.71 (d, 1 H). 19F NMR (338 MHz, CDCl3): δ
-77.22 (s). 13C NMR (90 MHz
CDCl3): δ 169.1, 160.5, 128.2, 124.8, 122.4
(q, J = 285.8 Hz), 113.8, 77.5
(q, J = 30.5 Hz), 64.3, 55.3,
13.9.
3,3,3-Trifluoro-2-hydroxy-2-(4-
t
-butylphenyl)-propionic acid
ethyl ester:
1H NMR (360 MHz,
CDCl3): δ 1.32 (s, 9 H), 1.38 (t, J = 7.0 Hz, 3 H), 4.30 (s, 1
H), 4.31-4.51 (m, 2 H), 7.42 (m, 2 H), 7.70 (d, 2 H, J = 8.3 Hz). 19F
NMR (338 MHz, CDCl3): δ
-76.93 (s). 13C NMR (90 MHz,
CDCl3): δ 169.2, 152.7, 130.0, 126.6, 125.5,
123.2 (q, J = 285.6 Hz), 77.8
(q, J = 30.9 Hz), 64.4, 34.7,
31.3, 14.0.
3,3,3-Trifluoro-2-hydroxy-2-(4-fluorophenyl)-propionic acid
ethyl ester:
1H NMR (360 MHz,
CDCl3): δ 1.38 (t, J = 7.5
Hz, 3 H), 4.39 (s, 1 H), 4.34-4.53 (m, 2 H), 7.09 (m, 2
H), 7.80 (m, 2 H). 19F NMR (338 MHz, CDCl3): δ -77.20
(s), -112.66 (q,
J = 9.1
Hz). 13C NMR (90 MHz, CDCl3): δ 168.75,
163.5 (d, J = 248.8 Hz), 128.9
(dd, J = 8.6 Hz, 2.7 Hz), 128.6
(d,
J = 3.3 Hz), 122.9
(q, J = 285.7 Hz), 115.4 (d, J = 22.8 Hz), 77.4 (q, J = 30.5 Hz), 64.6, 13.8.
3,3,3-Trifluoro-2-hydroxy-2-(4-chlorophenyl)-propionic acid
ethyl ester:
1H NMR (360 MHz,
CDCl3): δ 1.38 (t, 3 H, J = 7.5
Hz), 4.38 (s, 1 H), 4.30-4.52 (m, 2 H), 7.39 (d, 2 H, J = 8.6 Hz), 7.75 (d, 2 H). 19F
NMR (338 MHz, CDCl3): δ -77.09 (s). 13C NMR
(90 MHz, CDCl3): δ 168.7, 136.0, 131.4, 128.7,
128.5, 122.9 (q, J = 285.9 Hz),
77.5 (q, J = 30.6 Hz), 64.8,
13.9.
3,3,3-Trifluoro-2-hydroxy-2-(2,5-dimethylphenyl)-pro-pionic
acid ethyl ester:
1H NMR (360
MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.3
Hz), 3.82 (s, 3 H), 4.29 (s, 1 H), 4.33-4.52 (m, 2 H),
6.93 (d, 1 H,
J = 9.0
Hz), 7.71 (d, 1 H). 19F NMR (338 MHz, CDCl3): δ
-73.65
(s). 13C NMR (90 MHz, CDCl3): δ 169.9,
135.2, 134.5, 132.5, 131.3, 129.9, 128.0 (q, J = 3.8
Hz), 123.5 (q,
J = 288.1
Hz), 79.6 (q, J = 28.8 Hz),
64.1, 21.2, 20.0, 13.8.
3,3,3-Trifluoro-2-hydroxy-2-(2,4,6-trimethylphenyl)-propionic
acid ethyl ester:
1H NMR (360
MHz, CDCl3): δ 1.26 (t, J = 7.0
Hz, 3 H), 2.18 (s, 3 H), 2.35(s, 6 H), 3.23 (s, -OH), 4.17-4.33
(m, 2 H), 6.80 (s, 2 H). 19F NMR (338 MHz, CDCl3): δ -76.17
(s). 13C NMR (90 MHz, CDCl3): δ 168.5,
137.6, 137.5, 131.2, 126.8, 123.0 (q, J = 284.8
Hz), 80.3 (q, J = 30.2 Hz),
61.7, 21.6, 21.5, 19.4, 12.6.